Home

Articles from Extendicare Inc.

Extendicare Announces 2025 Third Quarter Results
MARKHAM, Ontario, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2025.
By Extendicare Inc. · Via GlobeNewswire · November 11, 2025
Extendicare Announces October 2025 Dividend of C$0.042 per Share
MARKHAM, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
By Extendicare Inc. · Via GlobeNewswire · October 15, 2025
Extendicare Announces Timing of 2025 Third Quarter Results and Conference Call
MARKHAM, Ontario, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the third quarter of 2025 after market close on Tuesday, November 11, 2025. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Executive Vice President and Chief Financial Officer, will be held on Wednesday, November 12, 2025, at 11:30 a.m. (ET) to discuss the results.
By Extendicare Inc. · Via GlobeNewswire · October 7, 2025
Extendicare Announces September 2025 Dividend of C$0.042 per Share
MARKHAM, Ontario, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
By Extendicare Inc. · Via GlobeNewswire · September 15, 2025
Extendicare Announces 2025 Second Quarter Results
MARKHAM, Ontario, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2025.
By Extendicare Inc. · Via GlobeNewswire · August 6, 2025
Extendicare Announces July 2025 Dividend of C$0.042 per Share
MARKHAM, Ontario, July 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
By Extendicare Inc. · Via GlobeNewswire · July 15, 2025
Extendicare Announces Timing of 2025 Second Quarter Results and Conference Call
MARKHAM, Ontario, July 07, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second quarter of 2025 after market close on Wednesday, August 6, 2025. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Executive Vice President and Chief Financial Officer, will be held on Thursday, August 7, 2025, at 11:30 a.m. (EDT) to discuss the results.
By Extendicare Inc. · Via GlobeNewswire · July 7, 2025
Extendicare Acquires Closing the Gap Healthcare Group
Extendicare increases Senior Secured Credit Facility to $375 million
By Extendicare Inc. · Via GlobeNewswire · July 2, 2025
Extendicare Announces Renewal of Normal Course Issuer Bid
MARKHAM, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under the terms of the NCIB, the Company may purchase for cancellation up to 7,281,193 of its common shares (the “Common Shares”), representing 10% of its public float of issued and outstanding Common Shares. As at June 20, 2025, there were 83,817,909 Common Shares issued and outstanding and the public float was 72,811,939 Common Shares, calculated in accordance with the rules of the TSX.
By Extendicare Inc. · Via GlobeNewswire · June 26, 2025